Brief: Cannassure Therapeutics And Lipidor AB To Develop Topical Medical Cannabis Products Based On AKVANO Technology
11/12/2019 19:44
Dec 11 (Reuters) - Cannassure Therapeutics Ltd CSURE.TA :
* CANNASSURE THERAPEUTICS LTD AND LIPIDOR AB ENTER A
FEASIBILITY
STUDY AND LICENCE OPTION AGREEMENT FOR DEVELOPMENT AND SALES OF
TOPICAL MEDICAL CANNABIS PRODUCTS BASED ON AKVANO TECHNOLOGY
* CANNASSURE THERAPEUTICS - SUBJECT TO SUCCESSFUL
FEASIBILITY
STUDY, CO HAS OPTION TO ENTER EXCLUSIVE GLOBAL LICENSE FOR USE
OF LIPIDOR'S TECHNOLOGY
* CANNASSURE THERAPEUTICS - TO IMPLEMENT LIPIDOR'S
TECHNOLOGY FOR
DEVELOPMENT & COMMERCIALIZATION OF SPRAYABLE MEDICAL CANNABIS
PRODUCTS BASED ON AKVANO
Source text for Eikon: ID:nPn6zv4nSa
Further company coverage: CSURE.TA LIPI.ST
((Reuters.Briefs@thomsonreuters.com;))